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ABSTRACT
AnintronichexanucleotideUGCAUGhasbeenshown
to play a critical role in the regulation of tissue-
specific alternative splicing of pre-mRNAs in a wide
range of tissues. Vertebrate Fox-1 has been shown to
bind to this element, in a highly sequence-specific
manner, through its RNA recognition motif (RRM).
In mammals, there are at least two Fox-1-related
genes, ataxin-2 binding protein 1 (A2BP1)/Fox-1 and
Fxh/Rbm9, which encode an identical RRM. Here, we
demonstrate that both mouse Fxh and A2BP1
transcripts undergo tissue-specific alternative spli-
cing, generating protein isoforms specific to brain
and muscle. These tissue-specific isoforms are char-
acterized for their abilities to regulate neural cell-
specific alternative splicing of a cassette exon, N30,
inthenon-musclemyosinheavychainII-Bpre-mRNA,
previously shown to be regulated through an intronic
distal downstream enhancer (IDDE). All Fxh and
A2BP1 isoforms with the RRM are capable of binding
to the IDDE in vitro through the UGCAUG elements.
Each isoform, however, shows quantitative differ-
ences in splicing activity and nuclear distribution in
transfectedcells.AllFxhisoformsandabrainisoform
of A2BP1 show a predominant nuclear localization.
Brain isoforms of both Fxh and A2BP1 promote N30
splicing much more efficiently than do the muscle-
specific isoforms. Skeletal muscles express addi-
tional isoforms that lack a part of the RRM. These
isoforms are incapable of activating neural cell-
specific splicing and, moreover, can inhibit
UGCAUG-dependent N30 splicing. These findings
suggest that tissue-specific isoforms of Fxh and
A2BP1 play an important role in determining tissue
specificity of UGCAUG-mediated alternative splicing.
INTRODUCTION
Alternative splicing of pre-mRNA is one of the fundamental
mechanisms for the regulation of gene expression in higher
eukaryotes (1,2). Developmentally regulated, cell type- or
tissue-speciﬁc, and signal-induced alternative splicing of
pre-mRNAs takes place in multicellular organisms throughout
their lifetimes. Misregulation or abnormalities in pre-mRNA
splicing, in some instances, leads to cellular dysfunctions
found in human and animal diseases (3–5). Using various
model systems of regulated alternative splicing, a number
of pre-mRNA features that inﬂuence alternative splice site
selection have been deﬁned (1,2). These include enhancer
and repressor RNA sequences located in exons and introns.
Identiﬁcation of RNA-binding proteins targeting these cis-
regulatory elements is currently in progress. In vertebrates,
participation of the SR family proteins and hnRNP proteins,
such as PTB and hnRNPA1, in alternative splicing regulation
via binding to the cis-regulatory elements have been shown
in many tissue-speciﬁc splicing models (6,7). Although these
RNA-binding proteins are ubiquitously expressed, their dif-
ferent abundance in different cells, differences in their post-
translational modiﬁcations in different cellular contexts and
their different abilities to assemble multiprotein complexes in
different pre-mRNA contexts are thought to contribute to
the determination of cell type-speciﬁc patterns of alternative
splicing. For the last few years, tissue-speciﬁc and tissue-
enriched RNA-binding proteins have begun to be identiﬁed
as splicing regulators. These include brain-speciﬁc (or
enriched) Nova-1, nPTB (brPTB) and some of the CELF fam-
ily proteins (8–12). Discovery of these proteins has had a great
impact on studies aimed at understanding the molecular mech-
anisms of alternative splicing regulation.
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doi:10.1093/nar/gki338Oneoftheintroniccis-elements,whichareinvolvedintissue-
speciﬁc ordifferentiationstage-dependentregulationofaltern-
ativesplicing,isthehexanucleotideUGCAUG.Theimportance
of this element was originally recognized in ﬁbronectin pre-
mRNAbyHuhandHynes(13).Sincethen,alternativesplicing
speciﬁc to a variety of tissues or cell types, including neural
cells,muscles,epithelialcellsanderythrocytes,hasbeenshown
to be modulated via this element (14–21). Recently, Jin et al.
(21) discovered that a zebraﬁsh homolog of Caenorhabditis
elegans Fox-1 (22) could bind speciﬁcally to the pentanuc-
leotide GCAUG by in vitro selection from randomized RNA
sequences.Thispentanucleotideisalmostidenticaltothehexa-
nucleotideUGCAUGexceptfortheﬁrstU.Moreover,thezeb-
raﬁshFox-1homolog,aswellasthemouseFox-1homolog,are
capable of repressing the inclusion of an alternative cassette
exon of the ATP synthase F1g pre-mRNA via binding to
GCAUG, which mimics muscle-speciﬁc exclusion of this
exon. This mouse homolog is identical to the ataxin-2 binding
protein1(A2BP1),whichhasbeenpreviouslyclonedinhumans
andmice asthe cDNAencoding aprotein,which interacts with
ataxin-2, the product of the causative gene for spinocerebellar
ataxia type 2 (23,24). In addition to A2BP1/Fox-1, another
mouse homolog of C.elegans Fox-1, Fxh, has been independ-
entlyclonedasacDNA,whichisinducedbyandrogeninmotor
neurons (25). Of note is that A2BP1/Fox-1 and Fxh share
an identical RNA recognition motif (RRM) at the amino acid
level.Therefore,twogenesinthemousegenomeencodehomo-
logs of nematode Fox-1. According to the names given by the
ﬁrst cDNA cloning, we used the nomenclature of A2BP1 and
Fxhinthisreport.A2BP1andFxhhavebeennamedA2BP1and
Rbm9, respectively, in the human and mouse genomes.
We have been studying regulatory mechanisms of neural
cell-speciﬁc alternative splicing using the non-muscle myosin
heavy chain II-B (NMHC-B) gene as a model system (14,26).
NMHC-B mRNA is expressed ubiquitously. However, an
alternative exon, N30, which encodes a 30 nt coding sequence,
isincludedinthemRNAsfromsomeneuralcells,butisskipped
in those from all other cells in mammals and birds (27,28). In
culturedcells,aswitchinN30splicingfromexclusiontoinclu-
sion can be seen in neural retinoblastoma Y79 cells during the
post-mitotic and differentiated stages triggered by butyrate
treatment.Wehavepreviouslydeﬁned anintronicdistaldown-
stream enhancer (IDDE), which confers neural cell speciﬁcity
on N30 inclusion, using this cell line (14). The IDDE includes
two copies of UGCAUG. Mutation of these hexanucleotides
resultsinN30skippinginpost-mitoticdifferentiatedY79cells.
In this study, we investigated the possible involvement of
A2BP1 and Fxh in the regulation of N30 splicing. To this
end, we have isolated cDNA clones for A2BP1 and
Fxh from brain and muscles. cDNA cloning revealed the
existence of tissue-speciﬁc (enriched) isoforms of both
A2BP1 and Fxh. Of importance, different isoforms of
A2BP1 and Fxh show different activities with respect to
N30 splicing as well as different subcellular localizations.
MATERIALS AND METHODS
Database disposition
Thesequencesreportedinthispaperhavebeendepositedinthe
GenBankdatabasewithaccessionnumbersAY659951(F011),
AY659952 (F411), AY659953 (F402), AY659954 (A016),
AY659955 (A030), AY659956 (A713), AY659957 (A715)
and AY659958 (A704).
RNA preparation and RT–PCR
Total RNAs were isolated from mouse tissues and cultured
cells using an RNA isolation kit (Stratagene) or an RNeasy
mini kit (Qiagen). To obtain the full-length coding regions of
cDNAs for Fxh and A2BP1, RT–PCRs were performed using
Superscript IIRNase H
  reverse transcriptase (Invitrogen) and
Pfu Turbo DNA polymerase (Stratagene). The PCR primers
used toobtain all Fxh cDNAs were 50-ctcaggcctccactagttATG-
GAGAAAAAGAAAATGGTAACTC-30 and 50-ctcaggcctcct-
ctagaaGTAGGGGGCAAATCGGCTGTA-30. The upstream
primers for the brain (A016 and A030) and muscle (A713,
A715 and A704) A2BP1 cDNAs were 50-ctcaggcctccactagtg-
ATGAATTGTGAAAGAGAGCAGCT-30 and 50-ctcaggcctc-
cactagtcATGTTGGCGTCGCAAGGAGTCC-30,respectively,
and the downstream primer for all A2BP1 cDNAs was
50-ctcaggcctcctctagagATATGGAGCAAAACGGTTGTATCC
-30. Lower case letters represent adapter sequences including
restriction enzyme sites. 50 Rapid ampliﬁcation of cDNA ends
(RACE) was performed using Marathon-Ready cDNA (BD
Biosciences Clontech). For the analysis of minigene and
NMHC-B mRNAs, RT–PCRs were performed as described
previously (14,26). Sequences of primers P1–P9 shown in
Figures 1, 4 and 6 are as follows: P1, 50-AATTCACCCAG-
CAACCAGAAT-30;P 2 ,5 0-TAGAGGGATGTAAGTGTTG-
ATGCC-30; P3, 50-CAGAGGGCGGACAGTGTATGGT-30;
P4, 50-GGCGGCAGGGGCGAGGGCAT-30; P5, 50-CCGTG-
GTCGCACCGTGTACAAC-30; P6, 50-CAGCGGCAGTGG-
CAGGGGTG-30; P7, 50-AGGAAGAAAGGACCATAATAT-
TCC-30;P 8 ,5 0-CCTCCACCCAGCTCCAGTTGT-30; and P9,
50-CCTGTAGTTATTAAATCCTTCAAG-30.
Preparation of expression constructs and minigenes
The cDNAs of Fxh and A2BP1 were introduced into a plasmid
pCS3 + MT, which contains a myc-epitope, and its modiﬁed
version pCS3 + MT + NLS, which in addition contains the
nuclear localization signal (NLS) of the SV40 large T antigen
(26). Minigenes G, J without the IDDE, and H with the wild-
type IDDE are the same as minigenes W, D4 and Cm0,
respectively in ref. (14). The 201 nt IDDEs with mutations
were generated by recombinant PCR using the appropriate
primers, which included mutated sequences. The hexanuc-
leotide TGCATG sequences at the 50 and 30 sides were chan-
ged to GTTACT and ACCTAC, respectively.
Electrophoresis mobility shift assay
Template DNAs for in vitro RNA transcription were prepared
by PCR using the wild-type and mutant IDDEs in the mini-
genes as templates and an upstream primer that included
the T7 promoter sequence at the 50 end. The probe and com-
petitor RNAs were transcribed by T7 RNA polymerase in the
presence of [a-
32P]UTP and a trace amount of [
35S]UTPaS,
respectively, using a MAXIscript kit (Ambion). Mole
concentrations of synthesized RNAs were estimated by
radioactivities. Fxh and A2BP1 proteins with a myc tag
were synthesized in vitro by using a TNT quick-coupled
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constructs, which include the SP6 promoter. Binding reactions
were carried out in a 10 ml mixture that contains 10 mM
HEPES (pH 7.9), 2 mM MgCl2, 50 mM KCl, 5% glycerol,
0.5 mM DTT, 5 mg tRNA, 1 ml reticulocyte lysate reaction
mixtureand 15fmolofprobe, on icefor20–30 min. Analiquot
of 5 mg of heparin was added to the reaction 10 min before gel
electrophoresis. The reaction mixtures were analyzed by elec-
trophoresis in a 6% polyacrylamide gel using a 0.5· TBE
buffer (Invitrogen).
Cell culture and transfection
The human retinoblastoma cell line Y79 was cultured and
transfected with DNAs as described previously (14,26).
Total amounts of transfected DNAs were adjusted to be con-
stant by addition of the empty vector. Either Lipofectin (Invit-
rogen) or Effectene transfection reagent (Qiagen) was used for
the transfection. For stable transfection, the pCS3+MT expres-
sion constructs were co-transfected with a plasmid carrying a
neomycin resistant gene and selected by 0.2 mM geneticin
(Invitrogen). For differentiation of Y79 cells, cells were
plated on the poly-D-lysine-coated plates and then treated
with 2.0–2.5 mM sodium butyrate for 4–5 days. HeLa cells
were cultured as described and transfected with DNA using
Effectene reagent (14,26).
Immunoblot analysis
Samples that required both protein and mRNA analysis were
split upon harvesting. Total cell proteins were subjected to
SDS–PAGE and blotted as described previously (26). The
primary antibodies used are monoclonal antibodies to a
myc-epitope (Invitrogen) and green ﬂuorescent protein
(GFP) (Clontech). Binding of antibodies was detected with
the SuperSignal System (Pierce) or ECL (Amersham).
Immunofluorescent microscopy
HeLa or Y79 cells grown in a four-chamber glass slide were
transfected as described above. Cells were ﬁxed with 10%
formaldehyde 24–48 h after transfection, and permealized
with 0.5% Triton X-100 then blocked with 5% goat serum.
Figure 1. (A) Schematic diagrams of Fxh and A2BP1 isoforms and summary of their subcellular distribution and splicing activities. The broken lines and broken
squares indicate the excluded and untranslated sequences, respectively. The light blue region has a reading frame shifted from the equivalent white region. The
relative activity of each isoform to the others are represented as numbers of +s; more ‘+’s are higher and   is no activity. ND, not determined; nls, exogenous
NLS-containingproteins;andwt,wild-typeproteins.(B)Schematicdiagramsoftheexon–intronorganizationsofmouseFxhandA2BP1genes.Rectanglesandsolid
lines in the diagrams indicate exons and introns. Zigzag lines of rectangles indicate undefined ends of exons. Exon and intron sizes are not drawn to scale.
2080 Nucleic Acids Research, 2005, Vol. 33, No. 7Primary antibodies used were mouse anti-myc (Invitrogen),
rabbit anti-NMHC-B (29). Secondary antibodies were Alexa
Fluor 594 goat anti-mouse IgG and Alexa Fluor 488 goat
anti-rabbit IgG (Molecular Probes). DAPI was used for
DNA staining. Specimens were mounted in ProLong antifed
kit (Molecular Probe). The images were collected using Leica
SP confocal microscopy (Leica).
RESULTS
Tissue-dependent isoforms of Fxh and A2BP1 and
their subcellular distribution
The A2BP1 mRNAs are detected almost exclusively in brain
and striated muscles (heart and skeletal muscles) in adult
mice, whereas the Fxh mRNAs are expressed in a wide vari-
ety of tissues with the highest expression in brain and heart
[(21,25) and S. Kawamoto, unpublished data]. These expres-
sion proﬁles prompted us to characterize the mRNAs of
A2BP1 and Fxh in brain and muscles. We have cloned
cDNAs for two gene transcripts from brain, heart and skeletal
muscles by RT–PCR and 50 RACE. The isolated cDNAs are
schematically presented with genomic structures in Figure 1
(for amino acid sequences see also Figure 8). Both gene
transcripts are found to undergo tissue-speciﬁc alternative
splicing. In both cases, brain and striated muscles express
unique splice variants generated by mutually exclusive spli-
cing of exons B40 and M43, respectively, which provide
different coding sequences in the middle of the carboxyl
half of the molecules. Southern blot analysis of the RT–
PCR products of the Fxh mRNAs from the different tissues
probed by oligonucleotides corresponding to B40 and M43
shows that M43 is exclusively used in heart and skeletal
muscles, while B40 is predominantly used in brain
(Figure 2A). Digestion of the RT–PCR products of the
A2BP1 mRNAs with restriction enzymes unique to B40
and M43 demonstrates that B40 and M43 are used almost
exclusively in brain and muscles, respectively (Figure 2B).
A2BP1 contains an additional cassette type alternative exon
A53, consisting of 53 nt. Inclusion and exclusion of exon A53
results in two different amino acid sequences at the C-
terminal region owing to a frame shift. In the case of the
A2BP1 gene, moreover, it appears that brain and striated
muscle utilize alternative promoters, resulting in different
amino acid sequences at the N-terminus. The 50 RACE of
skeletal muscle mRNAs yielded essentially a single species of
sequence with 29 unique N-terminal amino acids. The 50
RACE using brain mRNAs; however, yielded multiple pro-
ducts with multiple deduced amino acid sequences, all of
which differ from the muscle amino acid sequence at the
very N-terminus. Here, we focus our analysis on a clone
containing nine unique amino acids at the N-terminus,
which was obtained most frequently. Exon–intron organiza-
tion of Fxh and A2BP1 shows remarkable similarities and a
RRM is encoded in four exons (Figure 1B). Of note is that the
signiﬁcant amounts of Fxh and A2BP1 mRNAs from skeletal
muscles are missing a part of the RRM by exon skipping.
Typically, as shown in Figure 2C, they lack the 93 nt exon
that encodes RNP1, one of the two most critical motifs of
the RRM (30). Some of them lack almost the entire RRM
(e.g. F402 in Figure 1A).
To examine the subcellular distribution of each isoform of
Fxh and A2BP1, myc-tagged proteins were transiently
expressed in cultured cells and immunostained with an anti-
myc antibody. Initially, HeLa cells were used to investigate
subcellular localization, since these cells are more suited for
these studies. Representative confocal images are shown in
Figure 3A. DAPI and anti-NMHC-B antibodies serve as mark-
ers for nuclei and cytoplasm, respectively. As noted, the ratio
of protein distributed between nuclei and cytoplasm differs
among the proteins. All isoforms of Fxh have a predominant
nuclear localization. The brain isoform of A2BP1 without the
A53 exon (A016) localizes to both nuclei and cytoplasm,
whereas the other brain isoform with the A53 exon (A030)
localizes predominantly to cytoplasm with only a minimum
being in the nuclei. The relative amounts of both muscle iso-
forms of A2BP1 (A713 and A715) are somewhat between the
amounts of the two brain isoforms. These data are summarized
in Figure 1A. The subcellular distribution of representative
isoforms (F011, A016 and A030) was also examined in ret-
inoblastoma Y79 cells, which were used as host cells for the
transfection experiments in order to characterize splicing
activities of Fxh and A2BP proteins (see below). Although
Y79 cells have asphericalshape and have only thincytoplasm,
Figure 2. Tissue-dependent alternatively spliced isoforms of Fxh and A2BP1.
(A) Tissue-dependent mutually exclusive usage of exons B40 and M43 in the
FxhmRNAs.mRNAsisolatedfromtheindicatedtissuesweresubjectedtoRT–
PCR using primers P3 and P4 as indicated in Figure 1A. Ethidium bromide
staining(Etd.)ofagarosegelelectrophoresisofthePCRproductsandSouthern
blotsprobedbytheoligonucleotidesspecifictotheB40andM43areshown.Sk.
M, skeletal muscle. (B) Tissue-dependent mutually exclusive usage of exons
B40 and M43 in A2BP1 mRNAs. The RT–PCR products generated by using
primers P5 and P6 indicated in Figure 1A were digested with the restriction
enzymes (RE), BsgI (B) and PflMI (P), which uniquely cut B40 and M43,
respectively,orwereundigested( ).(C)ExpressionoftheRRM-defectiveFxh
mRNA in skeletal muscles. RT–PCR was carried out using primers P1 and P2
as indicated in Figure 1A. The 531 bp products contain the complete RRM
sequence. The 438 bp products lack the 93 nt exon, which encodes a part
of RRM.
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similar subcellular distribution as in HeLa cells (Figure 3B).
F011 localizes predominantly to nuclei, A016 to both nuclei
and cytoplasm and A030 predominantly to cytoplasm.
Specific interaction of Fxh and A2BP1 with IDDE
via a hexanucleotide UGCAUG
Fxh and A2BP1 share an identical RRM and A2BP1 has been
reported to bind speciﬁcally to the pentanucleotide GCAUG
through this RRM (21). We have previously reported that the
IDDE of the NMHC-B transcript, which is indispensable for
the regulation of neural cell-speciﬁc cassette type exon N30
splicing, has two copies of GCAUG (14). Therefore, we
investigated whether Fxh and/or A2BP1 bound to the
IDDE. Electrophoretic mobility shift assays (EMSAs) were
carried out using labeled IDDE and in vitro transcribed and
translated Fxh and A2BP1, which include a myc-epitope.
Since all Fxh and A2BP1 isoforms, except F402 and A704,
contain the identical RRM, representative isoforms were ana-
lyzed. The expression of F011 in reticulocyte lysate causes the
formation of a RNA–protein complex whose migration shift
distinguishes it from those of the control reticulocyte lysate (C
in Figure 4B, lanes 3 and 10). The unlabeled wild-type IDDE
competes with the probe efﬁciently for the formation of the
speciﬁc complex C (Figure 4B, lane 4). On the other hand, the
mutant mc (Figure 4A), which has a mutation in both copies of
UGCAUG, does not (Figure 4B, lane 7). The mutant ma,
which has a mutation in the hexanucleotide at the 50 side,
shows less efﬁcient competition, compared with mb, which
has a mutation in the 30 side of the hexanucleotide (Figure 4B,
lanes 5 and 6), indicating that the nucleotides at the 50 side are
more important than those at the 30 side. The presence of an
anti-myc antibody, but not a non-speciﬁc antibody,inhibits the
formation of the speciﬁc complex (Figure 4B, lane 8). Syn-
thesis of the full-length F011 protein using a reticulocyte
lysate and speciﬁcity of the myc antibody for the expres-
sed protein are veriﬁed by immunoblot analysis (Figure 4B,
lanes 11 and 12). A016 and A030 show essentially identical
results to those with F011 (data not shown). These results
indicate that Fxh and A2BP1 can bind to the IDDE and that
the hexanucleotide UGCAUG is required for their binding.
Fxh and A2BP1 enhance N30 inclusion in a
UGCAUG-dependent manner
To study whether Fxh and A2BP1 regulate neural cell-speciﬁc
splicing via binding to UGCAUG, the Fxh and A2BP1 expres-
sion constructs were co-transfected into retinoblastoma Y79
cells with a number of the reporter minigene constructs, which
include the wild-type or a mutant version of UGCAUG in the
IDDE (Figure 4A). Minigenes H and J consist of the exons E5,
N30 and E6 and their ﬂanking introns with some deletions
in the introns. The IDDE with or without mutations in the
Figure 3. Subcellulardistributionof theFxhandA2BP1 isoforms. Themyc-tagged proteinsindicatedwereexogenouslyexpressedin HeLacells (A) andY79 cells
(B).Immunofluorescenceconfocalimagesco-stainedwithanantibodytothemyc-epitope(red)aswellasthosetoNMHC-B(green)andDAPI(blue,fornuclei)are
shown. The two bottom images in each panel in (B) are overlays of red with blue (left) or green (right).
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Asdescribedabove, eachisoformofFxhandA2BP1entersthe
nucleus to a different extent. To see the effects of different
proteins on N30 splicing itself, independent of their differen-
tial properties in nuclear localization, an exogenous NLS was
added to the expressed proteins. Since Fxh and A2BP1 pro-
teins contain the identical RRM, and F011, A016 and A030
all show the same UGCAUG-dependent binding to the IDDE
in vitro, F011 and A030 were used for these experiments. Host
cells Y79 at the proliferating stage exclude the N30 exon
in  90% of the endogenous NMHC-B mRNAs (e.g. see
Figure 6A, lane 1).
As shown in Figure 4C, the mRNAs derived from minigene
J exclude N30 without exogenous expression of Fxh or A2BP1
in Y79 cells, similar to the endogenous NMHC-B mRNAs
(Figure 4C, upper panel, lanes 1–5). However, in the presence
of exogenous expression of F011 and A030, the N30 inclusion
is increased (Figure 4C, upper panel, lanes 7 and 12). The N30
inclusion is absolutely dependent on the presence of the IDDE
(Figure 4C, upper panel, lanes 6 and 11). Moreover, mutation
Figure 4. (A)SchematicdiagramsofminigeneconstructsandIDDE.Rectanglesandsolidlinesinthediagramsindicateexonsandintrons,respectively.Thebroken
linesindicatethedeletedintronregions.TheNMHC-Bgeneisflankedbythepreproinsulin(PPI)exons(E)2and3intheminigenes.Exonandintronsizesarenotin
scale.Thewild-type(wt)andmutant(ma,mbandmc)IDDEswereinsertedattheindicatedlocationofminigenesJandH.MinigeneGcontainsthe13kbfragmentof
the native gene. (B) UGCAUG-dependent interaction of Fxh with IDDE. EMSA was carried out using labeled wild-type IDDE as a probe and myc-tagged F011
protein(Prot.+), whichwere expressedinreticulocytelysate.Thespecific probe–protein complex(C)and thefree probe(F)are indicated.Theunlabeledwild-type
(wt) and mutant (ma, mb and mc) IDDEs shown in (A) were used as competitors (Comp.) at a concentration of 30-fold molar excess relative to the probe. Ab,
antibody; NS, non-specific; R, reticulocyte lysate alone; and  , no addition. Synthesis of the full-length protein in a reticulocyte lysate is verified by immunoblot
analysisusingananti-mycantibodyfollowingSDS–PAGE.(C)UGCAUG-dependentactivationofN30splicingbyFxhandA2BP1.Theminigenesindicatedwere
co-transfected with the expression constructs for the indicated proteins in Y79 cells. The mRNAs derived from the minigenes were analyzed by RT–PCR using
primers P7 and P8 indicated in (A). The 173 bp products include N30 (N30, +) and the 143 bp products exclude N30 (N30,  ). Immunoblots using an anti-myc
antibody show relative amounts of the expressed proteins.
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abolishes the inclusion of N30 (Figure 4C, upper panel,
lanes 8–10, 13–15). In the context of minigene H, which
contains shorter introns, the larger extent of N30 inclusion is
induced by either F011 or A030 overexpression (Figure 4C,
middle panel, lanes 7 and 12). The N30 inclusion of the mini-
gene H mRNAs also depends on the presence of the IDDE
(Figure 4C, middle panel, lanes 6 and 11). Mutation of both
copies of UGCAUG (mc) results in a complete loss of N30
inclusion (Figure 4C, middle panel, lanes 10 and 15). The mut-
ant ma shows stronger inhibition of N30 inclusion compared
with mb (Figure 4C, middle panel, lanes 8 and 9). This obser-
vation is consistent with the competition experiments of the
EMSA shown in Figure 4B, indicating that the 50 hexanuc-
leotideismoreimportantthanthe30 hexanucleotideforbinding
of Fxh or A2BP1 to the IDDE as well as an activation of N30
splicing.ComparableamountsofF011andA030areexpressed
in each transfection as veriﬁed by immunoblots using an anti-
myc antibody (Figure 4C, lower panel, lanes 6–17).
SinceminigenesJandHlackaportion ofthe intronbetween
exons N30 and E6 and, therefore, the IDDE is located  100 nt
downstream of N30, instead of 1.5 kb as in the native gene, we
also analyzed the effects of Fxh and A2BP1 on the N30 spli-
cing of the wild-type minigene G, which includes full-length
introns among E5, N30 and E6 (Figure 4A). As shown in
Figure 4C (right panel), both F011 and A030 are capable of
promoting N30 inclusion, with F011 showing a higher activity
(Figure4C,lanes16and17).AlthoughA030 canpromoteN30
inclusion as efﬁciently as F011 in the contexts of the minigene
J and H transcripts, it can do so less efﬁciently than F011 in the
context of the minigene G transcript. Interpretation of this
observation will be discussed below.
Taken together, Fxh and A2BP1 can activate N30 inclusion
in an IDDE-dependent manner. The hexanucleotide motif
UGCAUG is indispensable for this activation.
Differential activities of alternatively spliced isoforms
of Fxh and A2BP1 in promoting N30 inclusion
Both Fxh and A2BP1 mRNAs are expressed in brain and
A2BP1 is also expressed in striated muscles and Fxh is
expressed in an even wider variety of tissues. As demonstrated
above, however, both Fxh and A2BP1 transcripts undergo
tissue-dependent alternative splicing, producing muscle-
speciﬁc and brain-enriched isoforms. Therefore, the relative
activity of individual isoform of Fxh and A2BP1 in promoting
N30 inclusion was compared using minigene G.
First, in order to evaluate the relative speciﬁc activity of
each isoform in the splicing reaction separately from its ability
to localize to nuclei, an exogenous NLS was included in the
expressed protein to equalize the nuclear concentration of
the expressed protein in these experiments. Essentially, all
of the expressed proteins with the exogenous NLS are local-
ized to the nucleus (data not shown). Therefore, the relative
nuclear concentrations of the expressed proteins can be estim-
ated easily by immunoblots. As shown in immunoblots in
Figure 5A, similar quantities of proteins are expressed in a
dose-dependent manner. Expression of the brain isoform F011
causes a dose-dependent increase in N30 inclusion and the
extent of N30 inclusion reaches a plateau with  85% of the
mRNAs including N30. In contrast, inclusion of N30
promoted by F411, the predominant isoform from skeletal
muscles, reaches a plateau with only 40% of the mRNAs.
With respect to A2BP1, the brain isoform A030 shows
higher activity in N30 inclusion than the muscle isoform
A715, which shows almost no activation, as shown in Figure
5A. Including additional isoforms, the activities of individual
isoforms with an exogenous NLS in promoting N30 inclusion
are shown in Figure 5B (lanes 8–13) and are also summarized
in Figure 1A (nls). Special care was taken to ensure that a
similar quantity of each protein was expressed and, if not,
different amounts were tested to obtain comparable expres-
sion. In the presence of the exogenous NLS (nls), F011 and
A016 show the highest activities among all isoforms tested.
A30 shows a considerably lower activity than A016. Each of
the muscle isoforms (F411, A713 and A715) has a lower
activity than that of their brain counterparts (F011, A016
and A030, respectively). As expected, isoforms lacking a
part or all of the RRM (F402 and A704) have no activity
for N30 inclusion.
Figure 5. Differential activities of Fxh and A2BP1 isoforms in N30 splicing.
(A) The increasing amounts (0.05, 0.1, 0.2, 0.5, 1 and 2 mg, indicated by right
triangles) ofthe expressionconstructsfor the indicated proteins, whichinclude
a myc-epitope, were co-transfected in Y79 cells with minigene G as shown in
Figure4A.ThemRNAsderivedfromtheminigenewereanalyzedbyRT–PCR.
Dose-dependentproteinexpressionwasverifiedbyimmunoblot analysisusing
ananti-mycantibody.(B)Thevariousexpressionconstructsencodingthemyc-
tagged proteins indicated were co-transfected with minigene G and pEGFP.
RT–PCR of the minigene mRNAs and immunoblots using anti-myc and
anti-GFP antibodies are shown. GFP serves as an indicator for transfection
efficiency.
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without an exogenous NLS were examined. Representative
data are shown in Figure 5B (lanes 2–7) and the relative
activities are summarized in Figure 1A (wt). The protein
amounts detected by immunoblots in these experiments rep-
resent the total amounts of the proteins distributed to both the
nuclei and the cytoplasm. The splicing activities of the wild-
type proteins are consistent with the activities that combine the
splicing activities of the proteins with the exogenous NLS and
the activities of the native proteins to localize to nuclei. In the
absence of the exogenous NLS (wt), the brain isoforms F011,
and A016 to a lesser extent, are still capable of activating N30
inclusion efﬁciently. The muscle isoforms for both Fxh and
A2BP1 (F411, A713 and A715), as well as the brain isoform
A030, show only minimal activities. Therefore, F011 and
A016 appear to have the most physiological relevance to
N30 splicing activation.
Overexpression of Fxh and A2BP1 activates N30
inclusion of endogenous NMHC-B mRNAs
The human NMHC-B gene consists of 41 constitutive exons
and 3 alternative exons. Its pre-mRNA is  156 kb in length
and it is much more complex than the pre-mRNA from the
minigenes. In addition, the minigene pre-mRNAs are driven
by a heterologous promoter. Therefore, we next examined if
Fxh and A2BP1 were capable of promoting N30 inclusion of
the endogenous transcript. Y79 cells were stably transfected
withthe expression constructforF011orA016.BothF011and
A016 are enriched in the brain and show higher activation of
N30 inclusion in the minigene transcripts. mRNAs encoding
endogenous NMHC-B were analyzed by using RT–PCR. As
shown in Figure 6, the inclusion of exon N30 with and without
another alternative exon, R18, in the endogenous mRNAs is
markedly increased in the clones which were stably transfec-
ted with the construct for F011 or A016 containing an exo-
genous NLS (Figure 6, lanes 4 and 5). Although to a lesser
extent, transfection of the wild-type constructs without an
exogenous NLS also results in a signiﬁcant increase in N30
inclusion (Figure 6, lanes 2 and 3). Thus, exogenously
expressed Fxhand A2BP1 are capableof activating N30 inclu-
sion not only in the transcripts from the minigenes, but also in
those from the native NMHC-B gene in Y79 cells.
Fxh may cooperate with other factor(s) to promote
N30 inclusion
To address the role of endogenous Fxh and its potential inter-
action with other proteins in promoting N30 inclusion, we
made use of an isoform of Fxh, F402, which lacks the
RRM. The mutant proteins lacking an RRM for other
RNA-binding proteins have previously been reported to func-
tion in a dominant-negative fashion and inhibit the activities of
the wild-type proteins (26,31). Therefore, the effects of F402
on the N30 inclusion of minigene H mRNAs were examined
in the context of the Y79 cells treated with butyrate. Upon
butyrate treatment, as reported previously, Y79 cells enter in a
post-mitotic and differentiated stage, and importantly, the
endogenous as well as the minigene mRNAs in those cells
include N30 to a large extent, unlike those in the untreated
cells that predominantly exclude N30 (14). As shown in
Figure 7, in the absence of exogenous expression of F402,
large quantities of the mRNAs derived from minigene H-wt,
which contains the wild-type IDDE, include N30 (Figure 7,
upper panel, lane 4). In contrast, only small quantities of N30
inclusion are detected in the mRNAs from minigene H-mc,
which has mutations in both copies of UGCAUG in the IDDE
(Figure 7, upper panel, lane 8). Therefore, the butyrate-treated
Y79 cells contain factor(s), which are capable of activating the
UGCAUG-dependent N30 inclusion. Co-transfection of the
wild-type minigene H-wt with the F402 expression construct
causes a dose-dependent inhibition of N30 inclusion (Figure 7,
lanes 1–3), indicating that F402 has an antagonistic effect on
the endogenous factorswith respect to N30inclusion. Notably,
the UGCAUG-independent N30 inclusion seen in the mutant
minigene H-mc is not affected by the co-expression of F402
(Figure 7, lanes 5–7), indicating that the inhibitory activity of
F402 depends on the UGCAUG element. The parallel experi-
ment with the F011 expression construct does not show a
signiﬁcant effect on N30 splicing in either the wild-type or
mutant minigene (Figure 7, lanes 9–16). This may be due to
the fact that N30 inclusion of the wild-type minigene mRNAs
has already reached a maximal level and is consistent with the
idea that butyrate-treated Y79 cells contain sufﬁcient amounts
of protein(s) functionally equivalent to F011, which can pro-
mote N30 inclusion in a UGCAUG-dependent manner. Since
F402 does not bind to the UGCAUG element, and has a
UGCAUG-dependent antagonistic effect on N30 splicing, it
most probably disrupts protein–protein interactions of the
endogenous proteins that are required for the UGCAUG-
dependent activation of N30 splicing. Endogenous Fxh
(and/or A2BP1) would be a good candidate whose function
could be antagonized by exogenously expressed F402. Thus,
this observation suggests that the endogenous Fxh has an
effect on the activation of N30 splicing and that other
proteins cooperate with Fxh for N30 activation. Since muscle
cells express the RRM-defective isoforms to a signiﬁcant
extent (Figure 2C) and the wild-type F402 localize to
Figure 6. Increase in N30 inclusion of the endogenous NMHC-B mRNA by
exogenousexpressionofthebrain-enrichedisoformsofFxhandA2BP1inY79
cells.Y79cells were stablytransfected withexpressionconstructsforthe myc-
tagged proteins indicated. Endogenous NMHC-B mRNAs were analyzed by
RT–PCR. The 364 bp product includes another alternative exon R18 as well
as N30. The bottom diagram indicates the exon–intron organization of the
NMHC-B gene and location of the PCR primers (P7 and P9). Immunoblots
using an anti-myc antibody verify the expression of the myc-tagged proteins.
Nucleic Acids Research, 2005, Vol. 33, No. 7 2085nuclei efﬁciently, this also raises the possibility that the
RRM-defective isoforms may have an inhibitory function
on the N30 splicing in muscle cells.
DISCUSSION
Two major ﬁndings are described in this report. First, Fxh and
A2BP1 facilitate neural cell-speciﬁc inclusion of the cassette-
type exon via binding to the speciﬁc intronic sequence
UGCAUG. In addition to a minigene model system, Fxh
and A2BP1 are capable of facilitating N30 inclusion of the
endogenous pre-mRNA. This result provides an important
demonstration of physiological relevance and supports the
notion that the NMHC-B pre-mRNA is likely to be the true
target for Fxh or A2BP1-mediated regulation. However,
whether the endogenous Fxh or A2BP1 regulates endogenous
NMHC-B pre-mRNA splicing needs to be determined in a
future study. In vertebrates, small interfering RNAs and
gene targeting strategies have recently been used successfully
to address the roles of endogenous splicing regulators
in alternative splicing of endogenous target pre-mRNAs
(8,32–36). A second and more novel ﬁnding is the identiﬁca-
tion of tissue-speciﬁc isoforms of Fxh and A2BP1 with dif-
ferent splicing activities as well as different subcellular
localizations. This ﬁnding raises the possibility that the pro-
ducts of the Fxh and A2BP1 genes can contribute to a mech-
anism as to how tissue speciﬁcity of alternative splicing is
achieved.
Many splicing factorsare detectednot onlyinthe nuclei,but
also in the cytoplasm (37). They are shuttling between the
nucleus and the cytoplasm and, in some instances, extracel-
lularstimuli trigger changes insubcellulardistribution of these
proteins.Suchtranslocationshavebeen reportedforhnRNPA1
and PTB (38,39). Moreover, a number of RNA-binding pro-
teins have been demonstrated to play a role in multiple steps
during gene expression in different subcellular compartments,
such as pre-mRNA processing in nuclei, mRNA export from
nuclei to cytoplasm and mRNA localization, stability and
translation in cytoplasm (37,40). Therefore, not surprisingly,
Fxh and A2BP1 isoforms were found to be distributed in both
the nuclei and the cytoplasm in HeLa and Y79 cells. However,
the relative ratios of proteins distributed between the two
subcellular compartments at steady-state differ among the
isoforms.In agreement with Jinetal.(21), substantialamounts
of the brain isoform A016 are detected in nuclei. Other A2BP1
isoforms, the brain isoform A030 and the muscle isoforms
A713 and A715, are only poorly detected in nuclei. This
observation is consistent with the reports where endogenous
A2BP1 in cerebellar Purkinje cells, hippocampus neurons and
cardiac myocytes were shown to be localized essentially to the
cytoplasm (23,24). Thus, inclusion and exclusion of A53 and
differences in the very N-terminal sequences results in A2BP1
isoformswithadistinctsubcellularlocalization.Itislikelythat
A2BP1 proteins have multiple roles, involving both nuclear
and cytoplasmic events. In contrast, all three Fxh isoforms
predominantly localized to the nuclei. Therefore, in terms
of their localization, Fxh proteins are better candidates for
regulators of the pre-mRNA splicing that takes place in nuclei.
Of note, however, our preliminary results of 50 RACE, as well
as the EST database, detect multiple 50 end sequences for both
Fxh and A2BP1 mRNAs, which are presumably generated by
alternative promoters and alternative splicing. The diversity of
the 50 endcDNA sequencesleadstothegeneration ofanumber
of unique N-terminal amino acid sequences. Therefore, this
studydoes not exclude the possible existence of other isoforms
with different subcellular localizations for both Fxh and
A2BP1. Our study also does not exclude the possibility that
some of the isoforms translocate between the nucleus and the
cytoplasm following stimuli.
The main aim of this study is to determine the relative
activities of tissue-dependent isoforms of Fxh and A2BP1
in neural cell-speciﬁc and UGCAUG element-dependent
alternative splicing. To obtain an indication of the relative
speciﬁc activity of each isoform in transfected cells, the
same amounts of the expressed proteins should be available
for the splicing reaction in the nuclei. For this reason, an
exogenous NLSwas includedinthe expressedproteins. Essen-
tially, all of the expressed proteins with the exogenous NLS
localized to nuclei. Thus, the amounts of the expressed pro-
teins determined by immunoblots represent the nuclear con-
centrations. The analysis using the proteins expressed with the
exogenous NLS allowed us to compare directly the splicing
activities of these proteins. Furthermore, this analysis also
allowed us to deﬁne the critical regions of the proteins for
splicing activation.
As shown in Figure 5, the splicing activities of the various
isoforms of Fxh and A2BP1 are intrinsically different, regard-
less of the subcellular localization properties of the wild-type
proteins. Among the isoforms tested in this study, F011 and
A016, which include B40, are found to have higher activities
in promoting N30 inclusion. When the primary amino acid
sequences, outside of the RRM, of these two proteins are
compared, the C-terminal regions (amino acids 190–377 of
F011) show a higher homology with 71% identity, whereas the
N-terminal regions (amino acids 1–112 of F011) show only
53% identity. The C-terminal region includes four subregions
of nearly identical stretches of amino acids (Figure 8, I–IV).
One subregion (II) includes 13 amino acids encoded by exon
B40. Substitution of this subregion with exon M43 in Fxh
causes substantial changes in amino acid sequences resulting
in only a 21% identity in this region between F011 and F411.
Another subregion (IV) is located at the C-terminal end and
A030 lacks this homologous region by the inclusion of exon
Figure 7. Antagonistic effect of the RRM-lacking isoform of Fxh on
UGCAUG-dependent N30 inclusion in butyrate-treated Y79 cells. The indi-
cated minigenes (see Figure 4A for diagram) were co-transfected with increas-
ing amounts (0.7, 2 and 6 mg, indicated by right triangles) of the expression
construct for the indicated protein or with an empty vector in Y79 cells. The
cells were treated with butyrate to induce differentiation of Y79 cells. The
minigenemRNAswereanalyzedbyRT–PCR.Dose-dependentproteinexpres-
sion was verified by immunoblot analysis using an anti-myc antibody.
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poor splicing activation compared with F011 and A016,
respectively, these two subregions of F011 and A016 appear
to serve as activation domains, presumably by interacting
with other proteins. This notion is supported by the ﬁnding
that the RRM-lacking isoform F402, which includes the same
subregions II and IV as F011, functions apparently as a
dominant-negative mutant to the wild-type Fxh, consistent
with the interpretation that the mutant and wild-type are com-
peting to interact with other protein(s). To date, Fyn tyrosine
kinase and estrogen receptor-a have been reported to interact
with Fxh, and ataxin-2 with A2BP1 (23,41,42). Whether these
Figure 8. AminoacidsequencealignmentsofFxhandA2BP1isoforms.Shadedandstripedboxesindicateidenticalandsimilaraminoacids,respectively, toF011.
RRM and the amino acids encoded by exons B40 and M43 (B40/M43) as well as the highly homologous regions between F011 and A016 (I–IV) are indicated.
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currently unknown. Of interest, A030 with the exogenous NLS
activates N30splicingasefﬁcientlyasF011 inthe pre-mRNAs
derived from minigenes J and H, which contain the shorter
intron, whereas this isoform poorly activates N30 splicing in
the pre-mRNA from minigene G, which contains the full-
length intron. This observation implies that the interactions
of A030 with different factors are required in the different pre-
mRNA contexts. Therefore, the isoforms of Fxh and A2BP1
described here may have different effects on other UGCAUG-
regulated alternative splicing.
The involvement of the hexanucleotide UGCAUG in regu-
lated alternative splicing has been experimentally demon-
strated in a number of neural cell-speciﬁc, as well as other
tissue-speciﬁc, model systems (13–21). This hexanucleotide
element plays a role, in most cases, as an enhancer in regu-
lating alternative splicing of cassette-type exons as well as
mutually exclusive exons. Furthermore, computational ana-
lysis has revealed that UGCAUG is over-represented in the
introns in which splicing is regulated, compared with the con-
stitutively spliced introns (43). This analysis also pointed to
the UGCAUG element as playing a role in the regulation of
tissue-speciﬁc alternative splicing in a wide range of tissues,
but not in speciﬁc tissues.
To date, KH-type splicing regulatory protein (KSRP) (44),
A2BP1 (21) and Fxh (this study) are known to be capable of
binding to UGCAUG. KSRP is expressed ubiquitously and
tissue-speciﬁc variants of this gene have not been described
so far. In this study, we have described the existence of tissue-
dependent isoforms of Fxh and A2BP1, which, while not
identical in some areas of the molecule, may contain the
same RRM. The physiological relevance of these isoforms
is that they have different splicing activities and different
subcellular localizations. The brain isoforms promote N30
inclusion more efﬁciently than the muscle isoforms of both
Fxh and A2BP1. The isoforms lacking the RRM are normally
expressed to a signiﬁcant extent in skeletal muscles. This
isoform is incapable of activating N30 splicing and, moreover,
can inhibit N30 inclusion. The properties of these isoforms are
consistent with Fxh and A2BP1 acting as regulators for N30
splicing, since N30 is included in neuronal cells, but exclu-
ded in muscles. Therefore, despite the tissue-independent
occurrence of UGCAUG as a regulatory element, given the
tissue-dependent isoforms of the UGCAUG-binding proteins
(Fxh and A2BP1) with different activities, the hexanucleotide
UGCAUG could confer tissue speciﬁcity on regulated spli-
cing. One of the major problems in understanding the mech-
anisms responsible for alternative pre-mRNA splicing is the
manner in which tissue speciﬁcity is determined. In verteb-
rates, to date, only a few tissue-speciﬁc proteins have been
identiﬁed as splicing regulators (8–12). Here, we have shown
that the tissue-dependent isoforms of the sequence-speciﬁc
RNA-binding proteins, which themselves are generated by
alternative splicing, have different activities in tissue-
speciﬁc alternative splicing of target pre-mRNA. Therefore,
these isoforms play a role in the determination of tissue spe-
ciﬁcity of target pre-mRNA splicing. The discovery of these
tissue-dependent isoforms of the UGCAUG-binding proteins
withdifferent splicing activities adds an important new dimen-
sion to the molecular mechanisms responsible for regulating
tissue-dependent alternative splicing mediated via UGCAUG.
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